Posted by AGORACOM-JC
at 7:42 PM on Sunday, January 31st, 2021
Hollister Biosciences (HOLL:CSE) is a multi-state operator with multiple, high-quality products that are now carried in over 280 dispensaries throughout California and over 90 dispensaries throughout Arizona.
Q4 Highlights:
Record quarterly revenue of CDN$14.93 million and CDN$2.53 million in EBITDA
Venom Extracts is their 100% owned subsidiary that is absolutely dominating the state of Arizona. More than just lip service:
Since the closing (Venom), in the three quarters following, Venom contributed approximately CDN$38 million to the company’s 2020 revenue.
In the entire year of 2020,
Venom generated greater than CDN$ 40 million in revenue (and CDN$ 4.9 million in adjusted EBITDA),
Up from CDN$ 16.4 million in 2019 a 144% year over year revenue increase, and ending the year with a record month of sales for December totaling approximately CDN$5.5 million .
Sold over 4 million grams of product in 2020
accounting for up to 30 percent of category sales statewide in Arizona .
Positioned for continued growth in Arizona with the recently passed adult-use legislation
Marijuana Business Daily projects that Arizona’s recreational market could generate up to $400 million in revenue its first year and more than $700 million by 2024.
….. And it is run by the absolute coolest guy in small cap Cannabis – Jake Cohen
Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Both Cedar Psychiatry and Cedar Clinical Research are wholly-owned subsidiaries of Novamind. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit www.novamind.ca
Posted by AGORACOM-JC
at 9:31 AM on Friday, January 29th, 2021
Added former banking executive, Dana Ades-Landy to its Board of Directors
Over 25 years of experience in strategic development, governance and advocacy in the banking and financial services sector.
Experience includes: Senior positions at National Bank, KPMG, Laurentian Bank
Montreal, Quebec–(January 29, 2021) – Peak Fintech Group Inc. (CSE: PKK) (OTCQX: PKKFF) (“Peak” or the “Company”), an innovative Fintech service provider to the Chinese commercial lending sector, today announced that it has added former banking executive, Dana Ades-Landy to its Board of Directors.
Ms. Ades-Landy has over 25 years of experience in strategic development, governance and advocacy in the banking and financial services sector. She is currently in her second tour of duty with the National Bank of Canada where she works with the bank’s special loans group, managing a diverse portfolio of commercial and corporate clients while providing coaching and mentoring to the group’s less seasoned members. She first worked at the National Bank of Canada from 1993 to 2004 occupying various management and executive positions, culminating with the position of Vice-President, Credit Risk and Specialized Products.
Ms. Ades-Landy spent 3 years at KPMG as a Senior Vice-President and Associate providing the firm’s corporate clients with advice in the fields of insolvency, restructuring, turnaround, and business revitalization. She left KPMG in 2006 and went on to spend the following 10 years holding Senior Vice-President and Vice-President positions at the Laurentian Bank of Canada and Scotia Bank, respectively, before serving as CEO of the Quebec chapter of the Heart and Stroke Foundation of Canada from 2016 to August 2020.
Posted by AGORACOM-JC
at 8:15 AM on Friday, January 29th, 2021
Conference highlights industry leaders and innovators in the psychedelic therapy space and features Michael Pollan, author of New York Times bestseller, “How to Change Your Mind”
Will present at Canaccord Genuity’s “New Paradigms & Treatment Approaches in Mental Health” conference on February 3rd and 4th, 2021.
Two-day virtual conference will explore the science, intellectual property, and legality of psychedelic compounds, which are at the forefront of breakthrough medical science.
Novamind’s CEO and Director, Yaron Conforti will present on Wednesday February 3rd from 1:30-1:55 PM.
TORONTO, ON / January 29, 2021 / Novamind Inc. (CSE:NM) (“Novamind”), a mental health company specialized in psychedelic medicine, today announced that it will present at Canaccord Genuity’s “New Paradigms & Treatment Approaches in Mental Health” conference on February 3rd and 4th, 2021.
The two-day virtual conference will explore the science, intellectual property, and legality of psychedelic compounds, which are at the forefront of breakthrough medical science. Novamind’s CEO and Director, Yaron Conforti will present on Wednesday February 3rd from 1:30-1:55 PM.
Novamind, which has administered over 5,000 ketamine therapy treatments since 2016 and hosted over 20,000 client visits to its clinics in 2020 alone, will share its vision for scaling access to psychedelic medicine and advancing clinical research.
The conference will also feature keynote speaker Michael Pollan, author of the #1 New York Times bestseller “How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence.”
For more information about the conference, please click here.
Posted by AGORACOM-JC
at 10:32 AM on Thursday, January 28th, 2021
Tim Daniels / Executive Chairman of AI/ML Innovations Inc. / (CSE:AIML / OTC:FIRZF) explains how the Toronto-based business is focusing on acquiring and furthering Artificial Intelligence and Machine Learning technologies that can address urgent societal needs.
The firm’s key subsidiary, Health Gauge, is a leading digital health solutions provider that’s poised to disrupt the traditional healthcare industry by providing A.I. innovations and services that improve health outcomes, while at the same time reducing costs and stresses on the overburdened healthcare infrastructure.
AI/ML Highlights:
Recently showcased its proof-of-concept deployment in a study funded by The Bill and Melinda Gates Foundation
Health Gauge aims to penetrate the $245bn global digital health monitoring market by partnering with leading channel partners, health benefits providers, and end-users
Will do this via its proprietary combination of digital health monitoring devices, AI-based software, and cloud computing platform.
Take a seat and learn more about AI/ML and its ambitious vision for the future.
Posted by AGORACOM-JC
at 9:30 AM on Thursday, January 28th, 2021
Phil Waddington / President and CEO of Molecule Holdings Inc. / (MLCL:CSE) discusses the craft-focused, cannabis beverage production company’s cutting-edge work in the nascent Canadian market.
Boasting a 200,000 square foot production facility based in Ontario, the company has just been given the green light to begin selling its unique line of cannabis-infused beverages throughout Canada, starting in Ontario and Québec.
The company’s recent partnership with Vortex Cannabis Inc. allows Molecule to bring its unique line of cannabis-infused beverage products to market this year, while completing its own sales amendment application.
Molecule Highlights:
Molecule’s recent deal with Vortex Cannabis Inc. allows it to begin selling its unique line of cannabis-infused beverages throughout Canada this year.
Vortex will sell products produced by Molecule to provincial retailers, starting with Ontario and Québec.
Molecule has a 200,000 square foot production facility based in Ontario, offering huge capacity.
The company forecasts 2021 Q1 revenue of $3.5m, 2021 Q2 revenue of $5.8m, and a 2021 Run Rate revenue of $18.5m
An early leap of faith into this emerging industry in 2018 has positioned the company well ahead of the pack now.
“We are excited to move into full scale production and sale,” says CEO Phil Waddington.
Posted by AGORACOM-JC
at 9:22 AM on Thursday, January 28th, 2021
Barrett-Jackson Selects Draganfly to Utilize its Vital Intelligence Technology and Varigard Disinfectant Spraying Delivered by Drones at its March 2021 Auction
Announced Barrett-Jackson Auction Company (“Barrett-Jackson”) will implement Draganfly’s Safely Opening Sites protocol for its March 2021 collector car auction in Scottsdale, AZ.
Over the main auction days of Barrett-Jackson’s March event, Draganfly will provide its Vital Intelligence system kiosks, to provide employees with vital sign screening to help ensure a safer workplace environment and customer experience during the event.
Draganfly will also be providing spraying services using patented drone technology of the Varigard one-of-a-kind, revolutionary organic sanitizer that provides up to 24-hour of pathogen sequestration and kill-efficacy.
Los Angeles, CA., Jan. 28, 2021 — Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, today announced Barrett-Jackson Auction Company (“Barrett-Jackson”) will implement Draganfly’s Safely Opening Sites protocol for its March 2021 collector car auction in Scottsdale, AZ.
Established in 1971 and headquartered in Scottsdale, Arizona, Barrett-Jackson, The World’s Greatest Collector Car Auctions ® , is the leader in collector car auctions and automotive lifestyle events.
Over the main auction days of Barrett-Jackson’s March event, Draganfly will provide its Vital Intelligence system kiosks, to provide employees with vital sign screening to help ensure a safer workplace environment and customer experience during the event. Draganfly will also be providing spraying services using patented drone technology of the Varigard one-of-a-kind, revolutionary organic sanitizer that provides up to 24-hour of pathogen sequestration and kill-efficacy.
Draganfly’s Vital Intelligence technology Smart Vital assessment platform and telehealth app can automatically detect with voluntary consent body temperature, heart rate, respiratory rate, blood pressure and O2 saturation, all from a camera that takes seconds to capture the information. The technology will be deployed via a kiosk and smartphones.
Draganfly’s propriety Varigard 24hr pathogen sequestration and kill sanitizing spray applied via patented drone technology has also successfully helped enable the 2021 College Basketball season to open amid the COVID-19 Pandemic.
Posted by AGORACOM-JC
at 9:08 AM on Thursday, January 28th, 2021
Announced a strategic partnership with STEM Sports® with the goal of contributing to a Binovi Connect enabled curriculum for their K-8 programs.
STEM Sports® provides a turnkey K-8 supplemental curriculum that uses sports as the real-life application to drive STEM-based learning in classrooms, after-school programs, and camps.
STEM Sports® programs are currently active in a variety of school districts within 49 of the 50 US states.
January 28, 2021 – Toronto, New York – Binovi Technologies Corp., (Binovi) (TSXV:VISN ) | ( OTC:BNVIF ) | ( GR:2EYA), a leader in neuro-vision performance technology, is proud to announce a strategic partnership with STEM Sports® with the goal of contributing to a Binovi Connect enabled curriculum for their K-8 programs. STEM Sports® provides a turnkey K-8 supplemental curriculum that uses sports as the real-life application to drive STEM-based learning in classrooms, after-school programs, and camps. STEM Sports® programs are currently active in a variety of school districts within 49 of the 50 US states. Additionally, STEM Sports® has been awarded a STEM.orgAccredited™ Educational Experience trustmark!STEM.org Educational Research is the longest operating, privately held, STEM education research and credentialing organization in America, serving over 4,500 schools, districts, and organizations in over 25 countries.
“Investing in STEM-focused or STEM-based programs has proven time and time again to be a powerful way for companies to give back and to help promote new avenues of thinking. With this partnership, Binovi is teaming up with an already strong group in STEM Sports® to develop an important set of skills that often go overlooked. We’re excited for how Jeff and his team will be able to improve the lives —in the classroom, on the field, and in everyday life— of these young minds,” said Adam Cegielski, Binovi Founder & CEO.
“We have and will continue to collaborate with partners that see the value in investing in the education of today’s students so that they can enhance the future workforce. Binovi literally sees the opportunity to enhance the technology aspects that we provide in our curricula to the benefit of K-8 schools and afterschool programs,” said Jeff Golner, STEM Sports® President & CEO.
“Using athletics as a vehicle for learning is a powerful way to instill real-life skills into young minds that will drive them to succeed both in the game and in life. By joining forces with STEM Sports®, we aim to open their student athletes’ eyes to these new skills, as well as tools to promote skill advancement and performance improvement that will serve them in the same way now and throughout their lives,” commented Tania Archer, Binovi Head of Commercialization & Strategic Partnerships.
Posted by AGORACOM-JC
at 8:15 AM on Thursday, January 28th, 2021
Announced significant milestones at its Cedar Psychiatry clinics: administering over 5,000 ketamine treatments and over 2,000 Spravato™ treatments.
Clients receiving ketamine treatment at Novamind’s Cedar Psychiatry clinics are offered specialized therapy, pre- and post-ketamine-administration (ketamine-assisted psychotherapy).
Cedar Psychiatry specializes in evidence-based therapeutic protocols that facilitate the integration of ketamine experiences and optimize treatment outcomes for clients.
TORONTO, ON / January 28, 2021 / Novamind Inc. (CSE:NM) (“Novamind”), a leading mental health company specialized in psychedelic medicine, is proud to announce significant milestones at its Cedar Psychiatry clinics: administering over 5,000 ketamine treatments and over 2,000 Spravato™ treatments.
Launched in 2016, Cedar Psychiatry is a leading provider of innovative, evidence-based mental health therapies in the United States.
Clients receiving ketamine treatment at Novamind’s Cedar Psychiatry clinics are offered specialized therapy, pre- and post-ketamine-administration (ketamine-assisted psychotherapy). Cedar Psychiatry specializes in evidence-based therapeutic protocols that facilitate the integration of ketamine experiences and optimize treatment outcomes for clients.
The number of ketamine treatments administered at Cedar Psychiatry clinics grew 90% from 2019 to 2020. During the same period, total Spravato™ treatments at Cedar Psychiatry clinics have grown over 400%. Spravato™ is a version of ketamine that was approved by the U.S. FDA for treatment-resistant depression (TRD) in March 2019, and for major depressive disorder (MDD) with suicidal ideation or behaviour in August 2020. Clinical research studies that supported FDA approval showed that Spravato™ can effectively benefit people with these conditions, which can be difficult to treat.
“Spravato™ requires specialized infrastructure and processes that can be difficult for small mental health practices to implement, but Cedar Psychiatry has the scale and expertise to effectively manage the challenges of offering these novel medications to our clients,” commented Dr. Reid Robison, Chief Medical Officer and Director of Novamind.
“The need for innovative mental health services has never been greater. This demand is reflected in a sharp increase in visits to our clinics, and the growing adoption by our clients of alternative mental health treatments” added Yaron Conforti, CEO and Director of Novamind.
